STOCK TITAN

CNO Financial (NYSE: CNO) CEO sells 88,378 shares under 10b5-1 plan

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

CNO Financial Group Chief Executive Officer Gary C. Bhojwani reported open-market sales of company common stock under a pre-arranged Rule 10b5-1 trading plan adopted on August 21, 2025. These trades are designed to execute automatically according to preset instructions rather than day-to-day market timing decisions.

On February 18, 2026, he sold 43,021 shares at a weighted average price of $43.0511 per share, and on February 17, 2026, he sold 45,357 shares at a weighted average price of $43.1657 per share. After these transactions, he held 277,526 shares directly and 635,471 shares indirectly through the Gary C. Bhojwani Revocable Trust.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bhojwani Gary C.

(Last) (First) (Middle)
C/O CNO FINANCIAL GROUP, INC.
11299 ILLINOIS STREET, SUITE 200

(Street)
CARMEL IN 46032

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/17/2026 S 45,357(1) D $43.1657(2) 320,547 D
Common Stock 02/18/2026 S 43,021(1) D $43.0511(3) 277,526 D
Common Stock 635,471 I Gary C. Bhojwani Revocable Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025.
2. Reflects the weighted average sale price. Shares were sold at prices ranging from $42.93 per share to $43.715 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
3. Reflects the weighted average sale price. Shares were sold at prices ranging from $42.92 per share to $43.28 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
Remarks:
Heidi M. Krings, Attorney-in-Fact 02/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did CNO (CNO) report for CEO Gary Bhojwani?

CNO reported that CEO Gary C. Bhojwani sold common stock in two open-market transactions under a Rule 10b5-1 plan. He sold 45,357 shares on February 17, 2026 and 43,021 shares on February 18, 2026 at weighted average prices around $43 per share.

How many CNO (CNO) shares did the CEO sell and at what prices?

CEO Gary C. Bhojwani sold a total of 88,378 CNO common shares in two trades. He sold 45,357 shares at a weighted average of $43.1657 and 43,021 shares at a weighted average of $43.0511, with actual sales occurring within narrow price ranges around those averages.

Were the CNO (CNO) CEO stock sales made under a 10b5-1 trading plan?

Yes. The filing states the CEO’s sales were made under a Rule 10b5-1 trading plan adopted on August 21, 2025. Such plans allow insiders to pre-schedule stock sales, helping separate routine diversification or liquidity needs from day-to-day market timing decisions.

How many CNO (CNO) shares does the CEO still own after these transactions?

After the reported sales, CEO Gary C. Bhojwani held 277,526 CNO shares directly. He also had indirect ownership of 635,471 shares through the Gary C. Bhojwani Revocable Trust, reflecting both personal and trust-held positions remaining after the February 2026 trades.

What price ranges applied to the recent CNO (CNO) insider stock sales?

The weighted average prices were about $43 per share, but actual trades occurred across ranges. One set of sales ranged from $42.93 to $43.715 per share, and another from $42.92 to $43.28 per share, according to the detailed pricing footnotes.

What type of security did the CNO (CNO) CEO sell in the recent Form 4?

The insider transactions involved CNO Financial Group common stock, classified as non-derivative securities. The CEO executed open-market sales of these common shares under his Rule 10b5-1 trading plan, reducing his directly held position while maintaining a substantial remaining ownership stake.
Cno Finl Group Inc

NYSE:CNO

CNO Rankings

CNO Latest News

CNO Latest SEC Filings

CNO Stock Data

4.07B
92.32M
Insurance - Life
Accident & Health Insurance
Link
United States
CARMEL